Artivion, Inc. (CRY) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1152878,
    "name": "Artivion, Inc.",
    "stock_name": "Artivion, Inc.",
    "full_name": "Artivion, Inc.",
    "name_url": "stocks-analysis/artivion-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "45.41",
    "chg": -0.07,
    "chgp": "-0.15%",
    "dir": -1,
    "prev_price": "45.48",
    "mcapval": "2,114.25",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US2289031005",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "235.31 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/artivion-inc-1152878-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Artivion, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artivion-inc-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-3686151",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArtivionInc_technicaldot_3686151.png",
        "date": "2025-11-10 15:21:17",
        "description": "Artivion, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown notable resilience with a 54.83% return over the past year, significantly outperforming the S&P 500. Recent evaluations reflect mixed technical indicators, highlighting its strong recovery and robust market position."
      },
      {
        "title": "Artivion, Inc. Hits New 52-Week High of $47.69, Up 104%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artivion-inc-hits-new-52-week-high-of-4769-up-104-3680125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArtivionInc_priceRelatedfactors_3680125.png",
        "date": "2025-11-07 15:58:12",
        "description": "Artivion, Inc. has achieved a new 52-week high of USD 47.69, reflecting a significant increase in its stock price over the past year. With a market capitalization of USD 2,114 million, the company operates in a competitive sector, though it currently reports a negative return on equity."
      },
      {
        "title": "Artivion, Inc. Hits New 52-Week High of $46.58, Up 96.65%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artivion-inc-hits-new-52-week-high-of-4658-up-9665-3673986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArtivionInc_priceRelatedfactors_3673986.png",
        "date": "2025-11-05 16:28:46",
        "description": "Artivion, Inc. has achieved a new 52-week high, highlighting its impressive performance with a significant increase over the past year. The company, with a market capitalization of USD 2,114 million, operates in a competitive sector and currently shows a manageable debt level, despite being loss-making."
      },
      {
        "title": "Artivion, Inc. Hits New 52-Week High of $46.19, Up 96% Yearly",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artivion-inc-hits-new-52-week-high-of-4619-up-96-yearly-3661871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArtivionInc_priceRelatedfactors_3661871.png",
        "date": "2025-10-31 15:58:59",
        "description": "Artivion, Inc. has achieved a new 52-week high, showcasing a significant increase from its previous low and demonstrating strong performance compared to the S&P 500. With a market capitalization of USD 2,114 million, the company operates in a competitive sector, though it remains loss-making and does not offer dividends."
      },
      {
        "title": "Is Artivion, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-artivion-inc-technically-bullish-or-bearish-3545238",
        "imagepath": "",
        "date": "2025-09-20 19:07:00",
        "description": "As of 5 September 2025, the technical trend for Artivion, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating some positive momentum. However, the weekly and monthly RSI readings are bearish, suggesting potential weakness in price momentum. The Bollinger Bands show a bullish stance on the weekly and a mildly bullish stance on the monthly, supporting the overall mildly bullish trend. Daily moving averages are bullish, which is a positive sign for short-term traders. \n\nIn terms of returns, Artivion has outperformed the S&P 500 year-to-date with a return of 44.67% compared to 12.22%, and over one year with a return of 65.64% compared to 17.14%. However, the recent one-week and one-month returns are negative at -2.25% and -3.48%, respectively, while the S&P 500 has gained 1.05% and 2.33% in the same periods. Overall, the current te..."
      },
      {
        "title": "Is Artivion, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-artivion-inc-overvalued-or-undervalued-3541953",
        "imagepath": "",
        "date": "2025-09-20 17:40:34",
        "description": "As of 17 February 2022, the valuation grade for Artivion, Inc. has moved from attractive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued, particularly given its Price to Book Value of 4.35 and an EV to EBITDA ratio of 32.14, which are significantly higher than industry norms. Additionally, the company's Return on Capital Employed (ROCE) stands at a low 4.31%, while its Return on Equity (ROE) is negative at -4.00%, further highlighting its financial struggles.\n\nIn comparison to peers, MiMedx Group, Inc. has a fair valuation with a P/E ratio of 33.09 and an EV to EBITDA of 18.90, while Embecta Corp. is also deemed risky with a P/E of 6.42 and an EV to EBITDA of 6.59. This stark contrast underscores Artivion's challenging position within the industry. Despite a strong year-to-date return of 44.67% compared to the S&P 500's 12.22%, the overall valu..."
      }
    ],
    "total": 11,
    "sid": "1152878",
    "stock_news_url": "https://www.marketsmojo.com/news/artivion-inc-1152878"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Artivion, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-11-10 15:21:17

Artivion, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown notable resilience with a 54.83% return over the past year, significantly outperforming the S&P 500. Recent evaluations reflect mixed technical indicators, highlighting its strong recovery and robust market position.

Artivion, Inc. Hits New 52-Week High of $47.69, Up 104%

2025-11-07 15:58:12

Artivion, Inc. has achieved a new 52-week high of USD 47.69, reflecting a significant increase in its stock price over the past year. With a market capitalization of USD 2,114 million, the company operates in a competitive sector, though it currently reports a negative return on equity.

Artivion, Inc. Hits New 52-Week High of $46.58, Up 96.65%

2025-11-05 16:28:46

Artivion, Inc. has achieved a new 52-week high, highlighting its impressive performance with a significant increase over the past year. The company, with a market capitalization of USD 2,114 million, operates in a competitive sector and currently shows a manageable debt level, despite being loss-making.

Artivion, Inc. Hits New 52-Week High of $46.19, Up 96% Yearly

2025-10-31 15:58:59

Artivion, Inc. has achieved a new 52-week high, showcasing a significant increase from its previous low and demonstrating strong performance compared to the S&P 500. With a market capitalization of USD 2,114 million, the company operates in a competitive sector, though it remains loss-making and does not offer dividends.

Is Artivion, Inc. technically bullish or bearish?

2025-09-20 19:07:00

As of 5 September 2025, the technical trend for Artivion, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating some positive momentum. However, the weekly and monthly RSI readings are bearish, suggesting potential weakness in price momentum. The Bollinger Bands show a bullish stance on the weekly and a mildly bullish stance on the monthly, supporting the overall mildly bullish trend. Daily moving averages are bullish, which is a positive sign for short-term traders. In terms of returns, Artivion has outperformed the S&P 500 year-to-date with a return of 44.67% compared to 12.22%, and over one year with a return of 65.64% compared to 17.14%. However, the recent one-week and one-month returns are negative at -2.25% and -3.48%, respectively, while the S&P 500 has gained 1.05% and 2.33% in the same periods. Overall, the current te...

Is Artivion, Inc. overvalued or undervalued?

2025-09-20 17:40:34

As of 17 February 2022, the valuation grade for Artivion, Inc. has moved from attractive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued, particularly given its Price to Book Value of 4.35 and an EV to EBITDA ratio of 32.14, which are significantly higher than industry norms. Additionally, the company's Return on Capital Employed (ROCE) stands at a low 4.31%, while its Return on Equity (ROE) is negative at -4.00%, further highlighting its financial struggles. In comparison to peers, MiMedx Group, Inc. has a fair valuation with a P/E ratio of 33.09 and an EV to EBITDA of 18.90, while Embecta Corp. is also deemed risky with a P/E of 6.42 and an EV to EBITDA of 6.59. This stark contrast underscores Artivion's challenging position within the industry. Despite a strong year-to-date return of 44.67% compared to the S&P 500's 12.22%, the overall valu...

View All News